Waegener – Results study on cTreatment®

A randomized controlled study conducted by the Medical University of Graz (Austria) and the Onze Lieve Vrouwe Gasthuis of Amsterdam (the Netherlands) shows that the use of cTreatment® after principal knee arthroplasty (TKA) yields positive results.

“The new, computer-controlled cooling therapy offers benefits in terms of early post-operative remobilisation with respect to ROM and pain, which might be attributed to a reduced inflammatory response, as well as reduced secretion and bleeding. Therefore, the cTreatment® system appears to be a safe and efficient procedure. This makes it even clearer that Waegener’s cTreatment® is very efficient, says CEO Levi Dewaegenaere.

That is why the following was published in International Orthopedics 2017: Impact of a new cryotherapy device on early rehabilitation after primary total knee arthroplasty (TKA): a prospective randomised controlled trial.

This study was carried out by the following parties

Study performed by Patrick Sadoghi, MD, PhD1, Sandro Hasenhütl1, Gerald Gruber, MD1*, Andreas Leithner, MD1, Alexander Avian, MD2, Gudrun Rumpold-Seitlinger, MD3, Norbert Kastner, MD1, Rudolf W. Poolman, MD4, Mathias Glehr, MD1

1. Department of Orthopaedic and Trauma Surgery, Medical University of Graz, Austria
2. Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Austria
3. Division of Special Anaesthesiology, Pain and Intensive Care Medicine, Medical University of Graz, Austria
4. Department of Orthopaedic Surgery and Traumatology, Joint Research, OLVG, Amsterdam – The Netherlands.

Click here for more information about cTreatment®

About Levi Dewaegenaere

Levi Dewaegenaere grew from a professional tennis player to a successful entrepreneur. He is currently the founder and CEO of both Urban Capital Group and Waegener.

Follow Levi Dewaegenaere on LinkedIn

Follow Levi Dewaegenaere on Instagram

Follow Levi Dewaegenaere on Facebook

Follow Levi Dewaegenaere on Twitter